tetano
Editor, Senior Moderator
Clin Med (Lond)
. 2020 Jun 5;clinmed.2020-0301.
doi: 10.7861/clinmed.2020-0301. Online ahead of print.
Does Vitamin D Deficiency Increase the Severity of COVID-19?
E Kenneth Weir[SUP] 1 [/SUP], Thenappan Thenappan[SUP] 2 [/SUP], Maneesh Bhargava[SUP] 3 [/SUP], Yingjie Chen[SUP] 4 [/SUP]
Affiliations
Abstract
The severity of coronavirus 2019 infection (COVID-19) is determined by the presence of pneumonia, severe acute respiratory distress syndrome (SARS-CoV-2), myocarditis, microvascular thrombosis and/or cytokine storms, all of which involve underlying inflammation. A principal defence against uncontrolled inflammation, and against viral infection in general, is provided by T regulatory lymphocytes (Tregs). Treg levels have been reported to be low in many COVID-19 patients and can be increased by vitamin D supplementation. Low vitamin D levels have been associated with an increase in inflammatory cytokines and a significantly increased risk of pneumonia and viral upper respiratory tract infections. Vitamin D deficiency is associated with an increase in thrombotic episodes, which are frequently observed in COVID-19. Vitamin D deficiency has been found to occur more frequently in patients with obesity and diabetes. These conditions are reported to carry a higher mortality in COVID-19. If vitamin D does in fact reduce the severity of COVID-19 in regard to pneumonia/ARDS, inflammation, inflammatory cytokines and thrombosis, it is our opinion that supplements would offer a relatively easy option to decrease the impact of the pandemic.
Keywords: COVID 19; Treg; Vitamin D; coronavirus; inflammation.
. 2020 Jun 5;clinmed.2020-0301.
doi: 10.7861/clinmed.2020-0301. Online ahead of print.
Does Vitamin D Deficiency Increase the Severity of COVID-19?
E Kenneth Weir[SUP] 1 [/SUP], Thenappan Thenappan[SUP] 2 [/SUP], Maneesh Bhargava[SUP] 3 [/SUP], Yingjie Chen[SUP] 4 [/SUP]
Affiliations
- PMID: 32503801
- DOI: 10.7861/clinmed.2020-0301
Abstract
The severity of coronavirus 2019 infection (COVID-19) is determined by the presence of pneumonia, severe acute respiratory distress syndrome (SARS-CoV-2), myocarditis, microvascular thrombosis and/or cytokine storms, all of which involve underlying inflammation. A principal defence against uncontrolled inflammation, and against viral infection in general, is provided by T regulatory lymphocytes (Tregs). Treg levels have been reported to be low in many COVID-19 patients and can be increased by vitamin D supplementation. Low vitamin D levels have been associated with an increase in inflammatory cytokines and a significantly increased risk of pneumonia and viral upper respiratory tract infections. Vitamin D deficiency is associated with an increase in thrombotic episodes, which are frequently observed in COVID-19. Vitamin D deficiency has been found to occur more frequently in patients with obesity and diabetes. These conditions are reported to carry a higher mortality in COVID-19. If vitamin D does in fact reduce the severity of COVID-19 in regard to pneumonia/ARDS, inflammation, inflammatory cytokines and thrombosis, it is our opinion that supplements would offer a relatively easy option to decrease the impact of the pandemic.
Keywords: COVID 19; Treg; Vitamin D; coronavirus; inflammation.